Pharmazz, Inc.
PrivateLast Round
Seed Round
Jul 13, 2026
Est. Valuation
$110.13M
Total Funding Raised
$40.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pharmazz, Inc. is a biopharmaceutical company that develops and commercializes novel therapeutics to treat patients in critical care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmazz, Inc. Comparables
Compare Pharmazz, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NoNO Inc. | 82% | |
| Silver Creek Pharmaceuticals | 82% | |
| Vivacelle Bio | 82% |
Pharmazz, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 13, 2026 | ||||
| VC Round | Jun 11, 2025 | ||||
| Convertible Debt | Aug 21, 2024 | ||||
| Series A | May 23, 2024 | ||||
| Seed Round | Feb 2, 2024 | ||||
Seed | Oct 24, 2023 |
Pharmazz, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
$250K raised in Seed Round.
- Jul 13, 2026
Open roles increased to 7, 3.5x the trailing average.
Pharmazz, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharmazz, Inc.'s valuation, stock price, and market status.
Is Pharmazz, Inc. a public or private company?
Pharmazz, Inc. is a private company.
What is the current stock price of Pharmazz, Inc.?
Pharmazz, Inc. is a private company, so its shares have no public market price. Caplight tracks Pharmazz, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmazz, Inc. worth (valuation)?
Pharmazz, Inc.'s valuation is estimated at $110.1M based on funding round data.
Can I buy Pharmazz, Inc. stock?
Pharmazz, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmazz, Inc.'s last funding round?
Pharmazz, Inc.'s most recent funding round was Seed Round on July 13, 2026.
Who are the main investors in Pharmazz, Inc.?
Key investors in Pharmazz, Inc. include National Heart, Lung, and Blood Institute.
Will Pharmazz, Inc. IPO soon?
No public IPO plans have been announced for Pharmazz, Inc..
How can I track Pharmazz, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pharmazz, Inc.'s shares on secondary markets.